This content aligns with Goal 3: Good Health by emphasizing the importance of early diagnosis and comprehensive evaluation of hearing loss in children, which is crucial for preventing delays in speech, social development, and learning outcomes. By highlighting the genetic causes of hearing loss and the role of genetic testing, the chapter promotes effective interventions that can significantly improve health and developmental outcomes for affected individuals. Additionally, it supports Goal 10: Reduced Inequalities by advocating for accessible diagnostic processes and personalized care strategies that ensure all children, regardless of their background, receive the necessary support to address hearing loss and its associated challenges.

This review underscores the need for anti-racist research and publication practices that actively engage Aboriginal and Torres Strait Islander peoples and researchers. This approach is vital to enhance cancer outcomes within these communities.

This Editorial highlights disparities and inequalities in access to cancer screening and treatment (and consequently worse survival outcomes) in people with physical and intellectual disabilities.

This Review supports SDG 3 by showing that people with disabilities in Latin America and the Carribean face inequities with regard to health-care access, including some evidence showing worse affordability and quality of care. Addressing data gaps will be important to more fully assess health equity among people with and without disabilities in this region.

This Article supports SDGs 3 and 13 by estimating the association between environmental heat exposure and emergency department admissions for people with disabilities, compared with people without disabilities

This Comment supports SGDs 3 and 10 by discussing how the use of cashless payment systems in India can help to promote equitable access to health care and improve patient experiences, and well as examining some barriers to adoption.

Cancer disproportionately impacts Black patients in incidence and mortality. Accordingly, optimal anticancer pharmacotherapy is critical to improving outcomes in this population, however, Black patients are less likely to receive anticancer pharmacotherapy.

The study forecasts AI-based innovation's impact on SDGs in 22 countries from 2022 to 2030 using System Dynamics Modeling. In most of the 22 countries studied, AI-based innovation positively affects SDGs 1, 3, and 5. For half of the countries studied, AI-based innovation positively influences SDGs 2, 4, 6–8, 11, 13, and 16–17. AI-based innovation does not positively influence SDGs 10, 12, 14–15 for most countries studied.